Browsing Tag
AML diagnostics
1 post
Is Aptamer Group (LON: APTA) finally seeing sustained pharma traction with its Optimer platform?
Aptamer Group grows FY26 contracts to £1.95M with pharma repeat wins. Find out how its IP-heavy Optimer platform is gaining commercial traction.